CLINICAL_TRIALS
research
· 2025-07-16
Clinical Trial Update: AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. [NA]
Summary
AURORA is a Breast International Group-sponsored study to understand molecular aberrations in metastatic breast cancer. It is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Breast International Group | Conditions: Metastatic Breast Cancer | NA | Status: RECRUITING